June 26, 2007 the results and implications from the first nationwide MRSA Prevalence Study will be discussed at APIC’s 34th Annual Conference & International meeting. This [prevalence study exceeded all previous estimates and will provide out first picture of the threat MRSA poses to patients in facilities. This included all patients including acute care, cancer, cardiac, pediatric, rehabilitation and long term care. This Prevalence Study was financed by the APIC and data from more than 1,200 healthcare facilities in all fifty states was used to determine the current threat of MRSA.There have been a few national MRSA estimates that were limited in scope and size and therefore inaccurate.
Journalists wishing to participate in the press briefing in person or by telephone and/or arrange interviews please cal Jonathan Osmundsen at 202-261-2869, email Jonathan.Osmundsen@mslpr.com